One Pager as on July 31, 2023
Tax benefit with deduction under Section 80C of Income Tax Act, 1961* | |
3-year lock-in period to maximise growth potential | |
Potential Capital Appreciation through a diversified equity portfolio | |
*Assuming investor uses the entire ₹ 1.50 lac limit available under section 80C of the Income Tax Act 1961 for investing in Mahindra Manulife ELSS Fund. The tax benefit is calculated on the basis of current applicable tax rates under the old regime, ignoring marginal relief on surcharge, if any, for net taxable income between ₹ 50 lacs and ₹ 1 crore. The Finance Act 2020 has introduced a new income tax regime at concessional tax rates for individual taxpayers. However, the option for such concessional tax regime requires the taxpayer to forego certain solicited deductions including deduction u/s 80C of Income Tax Act. 1961. Please consult your financial / tax advisor before investing. |
Sector | MMEF | Nifty 500 TRI Index |
Financial Services | 31.70% | 31.83% |
Capital Goods | 9.05% | 4.49% |
Information Technology | 8.74% | 9.88% |
Automobile And Auto Components | 6.46% | 6.20% |
Consumer Durables | 5.45% | 3.56% |
Data as on July 31, 2023
Security | % to Net Assets |
HDFC Bank Limited | 8.90% |
ICICI Bank Limited | 7.29% |
Reliance Industries Limited | 5.27% |
Infosys Limited | 5.09% |
Axis Bank Limited | 4.26% |
Tata Consultancy Services Limited | 3.12% |
Bajaj Finance Limited | 2.91% |
Maruti Suzuki India Limited | 2.63% |
Larsen & Toubro Limited | 2.60% |
NTPC Limited | 2.14% |
Total | 44.21% |
Fresh Additions | Complete Exits |
Security | Security |
Alembic Pharmaceuticals Limited | Dr. Reddy's Laboratories Limited |
Lupin Limited | |
Marico Limited | |
Shree Cement Limited | |
Union Bank of India |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s).
Data as on July 31, 2023
Turnover Ratio (Last 1 year) | 0.60 |
Standard Deviation | 14.24% |
Beta1 | 0.93 |
Sharpe Ratio# | 1.26 |
Jenson's Alpha2 | 0.1446 |
#Risk-free rate assumed to be 6.60% (MIBOR as on 31-07-23) - Source:www.mmda.org
1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month since inception till July 31, 2023 and annualized. 2. Calculated for the period since inception till July 31, 2023 Data Source: ICRA Analytics, Bloomberg | Data as on July 31, 2023 | N.A.: Net Assets
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 18-Oct-16.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Fatema Pacha is managing this scheme since October 16, 2020. Mr Manish Lodha is managing this scheme since December 21,2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 18-Oct-16.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Fatema Pacha manage 8 schemes and
Mr. Manish Lodha manage 10 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on July 31, 2023
Note: ##Pursuant to change in Fund Management Responsibilities, the scheme shall be co-managed by Mr. Manish Lodha, Mr. Renjith Sivaram, Mr. Rahul Pal and Mr. Kush Sonigara (Dedicated Fund Manager for Overseas Investments)effective July 3, 2023.
This product is suitable for investors who are seeking*:
• Long term capital appreciation
• Investment predominantly in equity and equity related securities.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
*Assuming investor uses the entire ₹ 1.50 lac limit available under section 80C of the Income Tax Act 1961 for investing in Mahindra Manulife ELSS Fund. The tax benefit is calculated on the basis of current applicable tax rates under the old regime, ignoring marginal relief on surcharge, if any, for net taxable income between ₹ 50 lacs and ₹ 1 crore. The Finance Act 2020 has introduced a new income tax regime at concessional tax rates for individual taxpayers. However, the option for such concessional tax regime requires the taxpayer to forego certain solicited deductions including deduction u/s 80C of Income Tax Act. 1961. Please consult your financial / tax advisor before investing.